Friday November 27 2009 | Biotechnology feed | All feeds
|
|
Intercardia Incorporated
Download detailed PDF Members: Intercardia, Inc. discover, develop and add value to therapeutic products and to enter into collaborations or licensing agreements with corporate partners for commercialization, manufacturing and marketing. The Company's most advanced product is BEXTRA(TM) (bucindolol), for congestive heart failure ("CHF" or "heart failure"). The Company's other programs, focus on catalytic antioxidant small molecules as therapeutics for a variety of conditions (including neonatal respiratory distress syndrome and resulting broncho-pulmonary dysplasia, cardiomyopathy and stroke), and on hepatic stem cell research for treatment of liver disease.
This page has been viewed 608 times since April 2007, the link to the organisation's website has been followed 0 times Recent Search Terms used to find this page: intercardia | INTERCARDIA INC | intercardia incorporated | intercardia | intercardia | intercardia rtp nc | intercardia | intercardia | intercardia | Intercardia | . Search for more companies in Research Triangle Park Search for more companies in NC This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Intercardia Incorporated | ||||||||||||||||||||||||||||||||||||||||
|